Therapeutic Use of Brentuximab Vedotin in CD30+Hematologic Malignancies

Fabbri, A; Cencini, E; Gozzetti, A; Schiattone, L; Bocchia, M

Fabbri, A (reprint author), Univ Siena, Div Hematol, Siena, Italy.

ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2017; 17 (7): 886

Abstract

The CD30 antigen is strongly expressed on neoplastic cells in classical Hodgkin lymphoma (HL), anaplastic large cell lymphoma (ALCL) and other hematol......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索